The nature of consciousness, specifically the state of "pure consciousness"—often characterized in contemplative traditions as a state of awareness devoid of intentional content—has transitioned from a topic of purely philosophical inquiry to a rigorous subject of neuroscientific study. This review synthesizes current clinical and neurobiological research to propose that oxytocin (OT), a nonapeptide traditionally associated with social bonding and parturition, acts as a critical neuro-modulator of the ego-construct. By facilitating the down-regulation of the amygdala and modulating the Default Mode Network (DMN), oxytocin creates the necessary neuro-chemical substrate for non-dual awareness. We explore the neurobiology of the oxytocinergic system, the intersection of social salience and ego-dissolution, and the empirical evidence for OT-mediated shifts in self-referential processing. Finally, we discuss the ethical implications of using neuro-pharmacology to influence meditative states and propose future clinical pathways for treating psychiatric disorders characterized by rigid, pathological self-narratives.